Processing of Facial Expressions of Emotions and Pain in Alzheimer's Disease.

Alzheimer’s disease facial expression identification of pain pain intensity painful faces

Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2022
Historique:
pubmed: 25 7 2022
medline: 9 9 2022
entrez: 24 7 2022
Statut: ppublish

Résumé

Alzheimer's disease (AD) is a neurodegenerative pathology that disrupts processing of facial expressions of emotion. The impairment was demonstrated for negative emotions in tasks of matching, discriminating, and labeling facial expressions but no study has included the expression of pain in its protocol. The objective was to study the processing of emotional facial expressions in AD with a particular interest in pain expression. Twenty-seven controls, 15 mild AD patients, and 15 moderate AD patients had to perform four emotional tasks: identification of facial expressions, matching pain expressions, discriminating the intensity of pain expressions, and judging pain intensity. Some emotions were less efficiently recognized by AD patients compared to controls (p < 0.001), specifically fear from the mild stage (p < 0.05), pain and disgust from the moderate stage (p < 0.05 and p < 0.001 respectively). The Exploratory Factor Analysis showed that recognition of pain and recognition of other discreet emotions were underpinned by two different latent factors. Performances on pain expression matching task and pain intensity discrimination task did not differ by group. (p = 0.334 and p = 0.787 respectively). Finally, moderate AD patients judged the pain less intensively than the Control group for both, moderate, and severe pain intensity (p < 0.001). Our data suggest that AD disrupts the recognition of pain expression along with recognition of fear and disgust. Additionally, AD patients seem to underestimate pain intensity compared to controls. The self-rated pain scales should be adapted to the pain processing deficit of AD patients.

Sections du résumé

BACKGROUND
Alzheimer's disease (AD) is a neurodegenerative pathology that disrupts processing of facial expressions of emotion. The impairment was demonstrated for negative emotions in tasks of matching, discriminating, and labeling facial expressions but no study has included the expression of pain in its protocol.
OBJECTIVE
The objective was to study the processing of emotional facial expressions in AD with a particular interest in pain expression.
METHODS
Twenty-seven controls, 15 mild AD patients, and 15 moderate AD patients had to perform four emotional tasks: identification of facial expressions, matching pain expressions, discriminating the intensity of pain expressions, and judging pain intensity.
RESULTS
Some emotions were less efficiently recognized by AD patients compared to controls (p < 0.001), specifically fear from the mild stage (p < 0.05), pain and disgust from the moderate stage (p < 0.05 and p < 0.001 respectively). The Exploratory Factor Analysis showed that recognition of pain and recognition of other discreet emotions were underpinned by two different latent factors. Performances on pain expression matching task and pain intensity discrimination task did not differ by group. (p = 0.334 and p = 0.787 respectively). Finally, moderate AD patients judged the pain less intensively than the Control group for both, moderate, and severe pain intensity (p < 0.001).
CONCLUSION
Our data suggest that AD disrupts the recognition of pain expression along with recognition of fear and disgust. Additionally, AD patients seem to underestimate pain intensity compared to controls. The self-rated pain scales should be adapted to the pain processing deficit of AD patients.

Identifiants

pubmed: 35871339
pii: JAD220236
doi: 10.3233/JAD-220236
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-398

Auteurs

Romain Ceresetti (R)

Neurology/Neuropsychology CMRR Unit, Hospital Nord, Saint Priest-en-Jarez, France.

Isabelle Rouch (I)

Neurology/Neuropsychology CMRR Unit, Hospital Nord, Saint Priest-en-Jarez, France.
INSERM, U1219, Bordeaux Population Health Center, University of Bordeaux, Bordeaux, France.

Bernard Laurent (B)

Neurology/Neuropsychology CMRR Unit, Hospital Nord, Saint Priest-en-Jarez, France.
Lyon Neuroscience Research Center, INSERM U1028, Neuropain team, Bron, France.

Jean-Claude Getenet (JC)

Neurology/Neuropsychology CMRR Unit, Hospital Nord, Saint Priest-en-Jarez, France.

Morgane Pommier (M)

Neurology/Neuropsychology CMRR Unit, Hospital Nord, Saint Priest-en-Jarez, France.

Stéphanie de Chalvron (S)

SBT Human(s) Matter, Lyon, France.

Hanna Chainay (H)

University of Lyon, University Lyon2, EMC Laboratory (EA 3082), Bron, France.

Céline Borg (C)

Neurology/Neuropsychology CMRR Unit, Hospital Nord, Saint Priest-en-Jarez, France.
Psychology faculty, University of Lyon, Lyon, France.
University of Grenoble Alpes, University of Savoie Mont Blanc, CNRS UMR 5105, Laboratoire de Psychologie et Neurocognition (LPNC), Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH